University Hospital Limerick is a hospital located in Dooradoyle, Limerick, Ireland. It is managed by UL Hospitals Group.

There are 562 beds in University Hospital Limerick.

During the past decade, University Hospital Limerick conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 7 clinical trials were completed, i.e. on average, 17.9% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 7 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Limerick" #1 sponsor was "Cancer Trials Ireland" with 7 trials, followed by "University Hospital of Limerick" with 7 trials sponsored, "University of Limerick" with 7 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 6 trials sponsored and "ETOP IBCSG Partners Foundation" with 6 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Limerick" #1 collaborator was "University of Limerick" with 5 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "University Hospital of Limerick" with 2 trials as a collaborator and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Limerick" are "Cystic Fibrosis" (8 trials), "Cancer" (3 trials), "Breast Cancer" (2 trials), "COVID-19" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "University Hospital Limerick" in a lesser frequency.

Most popular intervention types in "University Hospital Limerick" are "Drug" (22 trials), "Other" (8 trials), "Procedure" (3 trials), "Behavioral" (2 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "IVA" (5 trials), "Placebo" (5 trials), "TEZ/IVA" (3 trials), "Epacadostat" (2 trials) and "Pembrolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Limerick" are 39 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "University Hospital Limerick". undefined are not yet recruiting, 6 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in University Hospital Limerick, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Limerick, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 9 trials that are defined as “Not Applicable".